The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Actavis, Inc.

  • ACT
  • NYSE
  • Consumer Products
  • Latest 243.21
  • Currency US$
  • Change 4.43
  • Percent Change 1.855 %
  • Volume 1,695,030
  • Thu Oct 30, 2014 04:04 PM EDT NYSE data delayed 15 minutes.
  • Open 238.36
  • Previous Close 238.78
  • High 243.87
  • Low 237.36
  • Bidx0 240.00
  • Askx0 248.70
  • 52-week High09/25 249.94
  • 52-week Low11/07 151.26
  • Beta 0.259
  • Market Cap 42,367.18M
  • EPS 12.17
  • P/E 19.984
  • Forward P/E 14.80
  • PEG 1.05
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $9,437,200,000
  • Earnings $-551,100,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow --
  • Cash $337,700,000
  • Current Ratio 1.51

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $22,403,900,000
  • Liabilities $12,775,300,000
  • Liabilities-to-Equity Ratio 1.33

Price Ratios

  • Price to Sales 4.49
  • Price to Book 4.40
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Aug 5 $3.37 Nov 5 $3.11
Surprises Aug 5 1.48% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Oct 31, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Actavis plc is a specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Its business is focused principally in the Urology and Women's Health therapeutic categories, as well as Gastroenterology and Dermatology. Actavis plc, formerly known as Actavis Inc., is headquartered in Parsippany, New Jersey, USA.

Related Securities
Symbol Type Latest % Chg

Officers

  • Paul M. Bisaro President; Chief Executive Off
  • R. Todd Joyce Chief Financial Officer
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

70 SIR JOHN ROGERSON`S QUAY
DUBLIN 2, L2
2

Phone: (216)-523-5000
Fax: (951)-2701096

investor.relations@actavis.com
www.actavis.com

Ideas & Discussion

Live Discussion of ACT on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.